RxDoctor Payments Data

Joseph Kukla, DPM

Podiatrist · Cedar Rapids, IANPI 1225342751

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Stryker at 33.0% of the total. 2025 is the largest year on record at $1,106, 4.5 times the $248 reported in 2019.

$2,679in general payments, 2019–2025

Across 100 payments — averaging $26.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$884
  • Organogenesis Inc.$475
  • Kerecis Limited$369
  • Treace Medical Concepts, Inc.$198
  • Zimmer Biomet$110
  • Smith+Nephew$89
  • plus $554 from 12 others

What the payments were for

  • Speaking & faculty fees$903%
  • Food & beverage$2,58997%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,679 in reported general payments places this provider in the 60th percentile of 94 podiatrist providers in Iowa.

See all podiatrist providers in Iowa

Medicare billing

Part B allowed, 2024
$253,396
Medicare patients
683
Services billed
3,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole18$345
Gentamicin Sulfate19$309
Terbinafine Hcl15$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$91
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$88
Cephalexin11$33
Meloxicam13$7

Paid to pharmacies, not to this prescriber.

Other podiatrist in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →